目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Research Methodology
Information Sources
Regional Breakdown
Segmentation Breakdown
Chapter- 2: Summary and Highlights
Market Outlook
Market Summary
Chapter- 3: Market Overview
Introduction
Biosimilars
Chapter- 4: Market Dynamics
Market Drivers
Market Challenges
Chapter- 5: Market Breakdown by Molecule Type
Global Market for Generic Drugs
Global Generic Drugs Market, by Molecule Type
Chapter- 6: Market Breakdown by Region
Introduction
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 7: Sustainability: An ESG Perspective
Introduction to ESG
Sustainability in the Generic Drugs Industry: An ESG Perspective
Environmental Performance of Key Generic Drug Companies
Social Performance of Key Generic Drug Companies
Governance Performance of Key Generic Drug Companies
Case Study
Concluding Remarks from BCC
Chapter- 8: Emerging Trends and Developments
Key Trends in the Market
Chapter- 9: Regulatory Landscape
Regulatory Overview
Regulation of Biosimilars
Authorized Generic Drugs
Chapter- 10: Competitive Landscape
Competitive Landscape
M&A Analysis
Chapter- 11: Company Profiles
ASPEN PHARMACARE
AUROBINDO PHARMA
CIPLA INC.
DR. REDDY'S LABORATORIES LTD.
FRESENIUS KABI
LUPIN LTD.
SANDOZ
SUN PHARMACEUTICAL INDUSTRIES LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC.
